Skip to content

Dermacyd Delicata Pocket BR - Photo Evaluation

Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Delicata Pocket BR.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00668226
Enrollment
25
Registered
2008-04-29
Start date
2007-12-31
Completion date
Unknown
Last updated
2009-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Hygiene

Brief summary

The purpose of this study is to prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Delicata Pocket BR.

Interventions

Sponsors

Sanofi
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Phototype Skin II and III * Integral skin test in the region

Exclusion criteria

* Lactation or gestation; * Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection * Diseases which can cause immunity decrease, such as HIV, diabetes * Use of drug photosensitizer * History of sensitivity or irritation for topic products * Active cutaneous disease which can change the study results * History or photodermatosis active * Family or personal antecedent of cutaneous photoinduced neoplasias * Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium * Intense solar exposure in the study area * Use of new drugs or cosmetics during the study The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Design outcomes

Primary

MeasureTime frame
The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type.5 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026